secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2023-05-16T23:59:59+00:00
Accession:  0001193125-23-145668
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus sells wound business to LifeNet Health for up to $85M
---------------------------------------------------------------

- Total cash consideration up to $85M: $35M at close, $5M deferred, $45M earn-out.
- Net proceeds ~$30M after fees and expenses will be used to repay existing debt.
- Divestiture reduces annual revenue by ~$40M and annual adjusted EBITDA by ~$5M.
- Transaction expected to close ~1 week before end of May 2023.
- Sales Agent Agreement grants LifeNet Health exclusive rights to sell SonicOne in US and Canada.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000119312523145668/0001193125-23-145668-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000119312523145668/d466754d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-145668

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer